Navigation Links
EquitiesIQ Initiates Coverage of Alliqua, Inc.
Date:1/14/2014

hether an investment in any particular security is consistent with their investment objectives, risk tolerance, and financial situation. EquitiesIQ and its affiliates are not recommending any investments based on the information in the research report.

Forward-looking Statements

This press release and the research report contain forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected. EquitiesIQ does not guarantee the accuracy and comprehensiveness of these predictions. You should not invest in the Alliqua in reliance on these forward-looking statements.

Please read the full disclosures and disclaimers at the end of the report as well as the general disclaimers and terms at http://equitiesiq.com/disclaimer.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11485599.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
2. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
3. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
4. Applied Genetics Initiates Commercial Operation
5. Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
6. Medbox, Inc. Initiates "Responsible Consumption" Campaign for Marijuana in Recreational States
7. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
8. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
9. Advanced Cell Diagnostics Initiates Agreement to Study Biomarkers for Cancer Immunotherapy
10. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
11. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014 Array Architects is proud ... expertise to the nation's hospitals and health systems. It ... those dedicating their careers to the advancement of both ... in her respective field, Laura Silvoy has been chosen ... 2014 Winter Simulation Conference. , Laura will present ...
(Date:11/18/2014)... , Nov. 18, 2014  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... progenitor cells) for complete cervical spinal cord injury ... "Top Advanced Therapies Projects to Watch" by Elsevier ... receive this significant industry honor, which represents independent ...
(Date:11/18/2014)... 2014  Novira Therapeutics, Inc., a privately held biopharmaceutical ... hepatitis B virus (HBV) infection, today announced that ... Scientific Advisory Board (SAB).  "We are ... Christian S. Schade , Chief Executive Officer of Novira.  ... will be invaluable to Novira as our lead core ...
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today the formation of a ... guidance to the Company as it advances the ... for the treatment of cutaneous T-cell lymphoma (CTCL), ...
Breaking Biology Technology:Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6
... to Detail Latest Cardiac Surgery Technology to be Held ... January 26th at 6:30 p.m. ... leading,medical technology companies will host the first annual After Hours ... aboard the yacht,"Princess Lady." The invitation-only event, immediately preceding the,largest ...
... Jan. 15 In response to the,Federal Drug ... are safe for human consumption, Smithfield Foods, Inc.,(NYSE: ... company is not planning,to produce meat products from ... relatively new. As thoughtful leaders in our industry,we ...
... BioSpecifics,Technologies Corp. (Pink Sheets: BSTC.PK) today announced ... stock, in a private placement,offering to an investment ... share for,aggregate proceeds to the Company of $2,100,000., ... Corp. is a biopharmaceutical company that has,developed and ...
Cached Biology Technology:Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 2Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 3Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 4
(Date:11/4/2014)... – (Nov. 4, 2014) – A majority of Madagascar,s ... that could have serious consequences for the rainforests they ... shows the positive impacts lemurs can have on rainforest ... their disappearance could have on the region,s rich biodiversity. ... have fruits eaten by lemurs. Lemurs in turn ...
(Date:11/3/2014)... report that low birth weight and preterm birth are ... in adulthood. Findings published in the American College of ... indicate that low birth weight and pre-term babies were ... OA as adults. , According to the ACR, ... diagnosed with clinical OA. Symptoms of OA range from ...
(Date:10/31/2014)... HMS Center for Biomedical Informatics (CBMI) has received two ... infusion of support will enable the center to continue ... and the other involving new approaches to precision medicine. ... National Human Genome Research Institute and the National Institute ... Center for Excellence in Genomic Science, or CEGS. , ...
Breaking Biology News(10 mins):Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Preterm, low birth-weight babies may need new hips in adulthood 2Transforming 'big data' into knowledge 2Transforming 'big data' into knowledge 3
... the first time, scientists have mapped the genome--the genetic code--of ... to maintain the genetic diversity of captive and wild orangutans. ... used to help improve our understanding of the evolution of ... Science Foundation, the orangutan study appears in the Jan. 27 ...
... What separates humans from Chimpanzees? Is it ... and behavior capabilities? To Professor Wallace Arthur it is ... book Evolution: A Developmental Approach sits between the ... approach to provide a complete view on the evolutionary ...
... release is available in German . , ... jointly develop new battery materials at KIT in the ... was signed by Professor Eberhard Umbach, President of KIT, ... Executive Directors of BASF SE, Ludwigshafen. The BELLA (Batteries ...
Cached Biology News:Scientists determine what makes an orangutan an orangutan 2Scientists determine what makes an orangutan an orangutan 3BASF and Karlsruhe Institute of Technology develop tomorrow's battery materials 2
...
Anti-MMP-7, aminoterminal end active enzyme; rabbit host...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Biology Products: